Clinical features in adult multiple sclerosis patients

a cross-sectional study

Authors

  • Matej Koprivnik University Medical Centre Maribor, Institute for Physical and Rehabilitation Medicine, Ljubljanska ulica 5, 2000 Maribor, Slovenia
  • Tanja Hojs Fabjan University Medical Centre Maribor, Department of Neurologic Diseases, Ljubljanska ulica 5, 2000 Maribor, Slovenia, and University of Maribor, Faculty of Medicine, Taborska ulica 8, 2000 Maribor, Slovenia https://orcid.org/0000-0003-0816-5101

DOI:

https://doi.org/10.14528/snr.2020.54.2.3016

Keywords:

multiple sclerosis, quality of life, neurological disability, functional ability

Abstract

Introduction: The purpose of the study was to identify possible correlations between the quality of life, neurological disability, and functional ability in patients with multiple sclerosis.
Methods: 258 patients with multiple sclerosis were included in the cross-sectional study. They were assessed with the Expanded Disability Status Scale (EDSS), the Berg Balance Scale (BBS), the Timed 25-Foot Walk Test (T25-FW), the 9-Hole Peg Test (9HPT), the Paced Auditory Serial Addition Test (PASAT-3) and the EQ visual analogue scale (EQ-VAS). Inferential statistics were used.
Results: A positive correlation between the EQ-VAS and the BBS (r = 0.43, p < 0.01 ) and the PASAT-3 (r =¸0.19, p < 0.01), and a negative correlation between the EQ-VAS and the T25FW (r = –0.42, p < 0.01) and the 9-HPT (r = –0.40, p < 0.01) were shown. A negative correlation was also observed between the EDSS and the BBS (r = –0.77, p < 0.05) as well as the EDSS and the PASAT-3 (r = –0.25, p < 0.01), and a positive correlation between the EDSS and the 9 HPT (r = 0.67, p < 0.01) and the T25-FW (r = 0.80, p < 0.01).
Discussion and conclusion: Associations between the variables indicate the need for complex, personalized and rational monitoring of patients with multiple sclerosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Amato, M.P. & Portaccio, E., 2007. Clinical outcome measures in multiple sclerosis. Journal of the Neurological Sciences, 259(1/2), pp. 118–122. https://doi.org/10.1016/j.jns.2006.06.031 PMid:17376487

Atteya, A., Elwishy, A., Kishk, N., Ismail, S.R. & Badawy, R., 2019. Assessment of postural balance in multiple sclerosis patients. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55(7), pp. 1–5. https://doi.org/10.1186/s41983-018-0049-4

Baumstarck-Barrau, K., Simeoni, M.C., Reuter, F., Klemina, I., Aghababian, V., Pelletier, J., et al., 2011. Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study. BMC Neurology, 11(17), pp. 1–10. https://doi.org/10.1186/1471-2377-11-17 PMid:1288343; PMCid:PMC3039581

Berg, K., Wood-Dauphinee, S., Williams, J.I. & Gayton, D., 1989. Measuring balance in the elderly: preliminary development of an instrument. Physiotherapy Canada, 41(6), pp. 304–311. https://doi.org/10.3138/ptc.41.6.304

Bethoux, F.A., Palfy, D.M. & Plow M.A., 2016. Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic. International Journal of Rehabilitation Research, 39(2), pp. 134–139. https://doi.org/10.1097/MRR.0000000000000157 PMid:26926380; PMCid:PMC4850097

Cohen, J.A., Reingold, S.C., Polman, C.H., Wolinsky, J.S. & International Advisory Committee on Clinical Trials in Multiple Sclerosis, 2012. Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lacent Neurology, 11(5), pp. 467–476. https://doi.org/10.1016/S1474-4422(12)70059-5

Cutter, G.R., Baier, M.L., Rudick, R.A., Cookfair, D.L., Fischer, J.S., Petkau, J., et al., 1999. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain, 122(5), pp. 871–882. https://doi.org/10.1093/brain/122.5.871 PMid:10355672

EuroQol Group, 2017. EQ-5D-3L /About. Rotterdam: EuroQol Group. Available at: https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/ [11. 11. 2019].

European Multiple Sclerosis Platform & Rehabilitation in Multiple Sclerosis, 2012. Recommendations on rehabilitation services for persons with Multiple Sclerosis in Europe. Brussels: European Multiple Sclerosis Platform, p. 59. Available at: http://www.emsp.org/wp-Content/uploads/2015/11/12-0431_Henze-30-04-12.pdf [6. 7. 2019].

Feys, P., Lamers, I., Francis, G., Benedict, R., Phillips, G.,LaRocca, N., et al., 2017. The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Multiple Sclerosis Journal, 23(5), pp. 711–720. https://doi.org/10.1177/1352458517690824 PMid:28206826; PMCid:PMC5405844

Fischer, J.S, Jak, A.J., Kniker, J.E., Rudick, R.A. & Cutter, G., 2001. Multiple Sclerosis Functional Composite (MSFC). Administration and scoring manual. National Multiple Sclerosis Society, pp. 1–44. Available at: http://main.nationalmssociety.org/docs/HOM/MSFC_Manual_and_Forms.pdf [16. 11. 2019].

Fjeldstad-Pardo, C., Pardo, G., Frederiksen, C., Bemben, D.A. & Bemben, M., 2009. Assessment of postural balance in multiple sclerosis. International Journal of MS Care, 11, pp. 1–5. https://doi.org/10.7224/1537-2073-11.1.1

Goldman, M.D., Motl, R.W. & Rudick, R.A., 2010. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 3(4), pp. 229–239. https://doi.org/10.1177/1756285610374117 PMid:21179614; PMCid:PMC3002657

Højsgaard Chow, H., Schreiber, K., Magyari, M., Ammitzbøll, C., Börnsen, L., Romme Christensen, J., et al., 2018. Progressive multiple sclerosis, cognitive function, and quality of life. Brain and Behavior, 8(2), pp. 1–7. https://doi.org/10.1002/brb3.875 PMid:29484253; PMCid:PMC5822575

Hutchinson, B., Forwell, S.J., Bennett, S., Brown, T., Karpatkin, H. & Miller, D., 2009. Toward a consensus on rehabilitation outcomes in MS: gait and fatigue. Report of a CMSC Consensus Conference, November 28-29, 2007. International Journal of MS Care, 11, pp. 67–78. https://doi.org/10.7224/1537-2073-11.2.67

Jones, K.H., Ford, D.V., Jones, P.A., John, A., Middelton, R.M., Lackhart Jones, H., et al., 2013. How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS Register. PLoS One, 8(6), pp. 1–8. https://doi.org/10.1371/journal.pone.0065640 PMid:23776516; PMCid:PMC36791547

Karabudak, R., Dahdaleh, M., Aljumah, M., Alroughani, R., Alsharoqi, I.A., AlTahan, A.M., et al., 2015. Functional clinical outcomes in multiple Sclerosis: current status and future prospects. Multiple Sclerosis and Related Disorders, 4(3), pp. 192–201. https://doi.org/10.1016/j.msard.2015.03.004 PMid:26008936

Kieseier, B.C. & Pozzilli, C., 2012. Assessing walking disability in multiple sclerosis. Multiple Sclerosis Journal, 18(7), pp. 914–924. https://doi.org/10.1177/1352458512444498 PMid:22740603

Kurtzke, J.F., 1983. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33(11), pp. 1444–1452. https://doi.org/10.1212/WNL.33.11.1444 PMid:6685237

Łabuz Roszak, B., Kubicka-Bączyk, K., Pierzchała, K., Horyniecki, M., Machowska-Majchrzak, A., Augustyńska-Mutryn, D., et al., 2013. Quality of life in multiple sclerosis – association with clinical features, fatigue and depressive syndrome. Psychiatria Polska, 47(3), pp. 433–441.

Lysandropoulos, A.P. & Havrdova, E., 2015. 'Hidden' factors influencing quality of life in patients with multiple sclerosis. European Journal of Neurology, 22(Suppl 2), pp. 28–33. https://doi.org/10.1111/ene.12801 PMid:26374511

Matias-Guiu, J.A., Cortés-Martínez, A., Valles-Salgado, M., Oreja-Guevara, C., Pytel, V. & Montero, P., 2017. Functional components of cognitive impairment in multiple sclerosis: a cross-sectional investigation. Frontiers in Neurology, 8(643), pp. 1–9. https://doi.org/10.3389/fneur.2017.00643 PMid:29234305; PMCid:PMC5712315

Meyer-Moock, S., Feng, Y.S., Maeurer, M., Dippel, F.W. & Kohlmann, T., 2014. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurology, 14(58), pp. 1–10. https://doi.org/10.1186/1471-2377-14-58 PMid:24666846; PMCid:PMC3986942

Motl, R.W., Cohen, J.A., Benedict, R., Phillips, G., LaRocca, N., Hudson, L.D., et al., 2017. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Multiple Sclerosis Journal, 23(5), pp. 704–710. https://doi.org/10.1177/1352458517690823 PMid:28206828; PMCid:PMC5405807

National Multiple Sclerosis Society, 2019. Paced Auditory Serial Addition Test (PASAT). Available at: https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Paced-Auditory-Serial-Addition-Test-(PASAT) [12. 11. 2019].

Nowinski, C.J., Miller, D.M. & Cella, D., 2017. Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials. Neurotherapeutics, 14, pp. 934–944. https://doi.org/10.1007/s13311-017-0571-6 PMid:28913785; PMCid:PMC5722775

Opara, J.A., Jaracz, K. & Brola, W., 2010. Quality of life in multiple sclerosis. Journal of Medicine and Life, 3(4),pp. 352–358.

Ozakbas, S., Cagiran, I., Ormeci, B. & Idiman, E., 2004. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences, 218(1/2), pp. 3–7. https://doi.org/10.1016/j.jns.2003.09.015 PMid:14759626

Ozakbas, S., Turkoglu, R., Tamam, Y., Terzi, M., Taskapilioglu, O., Yucesan, C., et al., 2018. Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: multi-center, controlled trial. Multiple Sclerosis and Related Disorders, 22(2018), pp. 70–76. https://doi.org/10.1016/j.msard.2018.03.009 PMid:29605801

Papuć, E. & Stelmasiak, Z., 2012. Factors predicting quality of life in a group of Polish subjects with multiple sclerosis: accounting for functional state, socio-demographic and clinical factors. Clinical Neurology and Neurosurgery, 114(4), pp. 341–346. https://doi.org/10.1016/j.clineuro.2011.11.012 PMid:22137087

Piri Çinar, B. & Güven Yorgun, Y., 2018. What we learned from the history of multiple sclerosis measurement: expanded disability status scale. Archives of Neuropsychiatry, 55(Suppl 1), pp. 69–75. https://doi.org/10.29399/npa.23343 PMid:30692861; PMCid:PMC6278618

Prosperini, L. & Castelli, L., 2018. Spotlight on postural control in patients with multiple sclerosis. Degenerative Neurological and Neuromuscular Disease, 8, pp. 25–34. https://doi.org/10.2147/DNND.S135755 PMid:30050386; PMCid:PMC6053902

Reese, J.P., Wienemann, G., John, A., Linnemann, A., Balzer- Geldsetzer, M., Mueller, U.O., et al., 2013. Preference-based health status in a German outpatient cohort with multiple sclerosis. Health and Quality of Life Outcomes, 11(162), pp. 1–9. https://doi.org/10.1186/1477-7525-11-162 PMid:24089999; PMCid:PMC3851447

Rugelj, D. & Palma, P., 2013. Bergova lestvica za oceno ravnotežja. Berg balance scale. Fizioterapija, 21(1), pp. 15–25.

Shapiro, R.T., 2011. Best practices in comprehensive MS symptomatic management. Reports from a CMSC Consensus Conference: team approach to complex symptomatic management in multiple sclerosis. International Journal of MS Care, 13(Suppl 4), p. 12. https://doi.org/10.7224/1537-2073-13.S4.1 PMid:24453699; PMCid:PMC3882948

Slavkovic, S., Golubovic, S., Vojnovic, M. & Nadj, C., 2019. Influence of cognitive and motor abilities on the level of current functioning in people with multiple sclerosis. Zdravstveno Varstvo, 58(2), pp. 54–61. https://doi.org/10.2478/sjph-2019-0007 PMid:30984295; PMCid:PMC6455014

Tiftikçioğlu, B.I., 2018. Multiple Sclerosis Functional Composite (MSFC): scoring instructions. Archives of Neuropsychiatry, 55(Suppl 1), pp. S46–S48. https://doi.org/10.29399/npa.23330

van Winsen, L.M.L., Kragt, J.J., Hoogervorst, E.L.J., Polman, C.H. & Uitdehaag, B.M.J., 2010. Outcome measurement in multiple sclerosis: detection of clinicaly relevant improvement. Multiple Sclerosis, 16(5), pp. 604–610. https://doi.org/10.1177/1352458509359922 PMid:20086019

Yalachkov, Y., Soydas, D., Bergmann, J., Frisch, S., Behrens, M., Foerch, et al., J. 2019. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Multiple Sclerosis and Related Disorders, 30, pp. 33–37. https://doi.org/10.1016/j.msard.2019.01.049 PMid:30735970

Ysrraelit, M.C., Fiol, M.P., Gaitán, M.I. & Correale, J., 2018. Quality of life assessment in multiple sclerosis: different perception between patients and neurologists. Frontiers in Neurology, 8(729), pp. 1–6. https://doi.org/10.3389/fneur.2017.00729 PMid:29375468; PMCid:PMC5769192

Downloads

Published

2020-06-23

How to Cite

Koprivnik, M., & Hojs Fabjan, T. (2020). Clinical features in adult multiple sclerosis patients: a cross-sectional study. Slovenian Nursing Review, 54(2), 104–112. https://doi.org/10.14528/snr.2020.54.2.3016

Issue

Section

Original scientific article